Home›Trial›NCT06836557
🔬NCT06836557Phase 3RECRUITING

Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis

Study Summary

This is a multicenter, open label, 3-month safety study with tradipitant in patients with idiopathic and diabetic gastroparesis.

Conditions
Idiopathic GastroparesisDiabetic GastroparesisGastroparesis
Interventions / Drugs
Tradipitant
View on ClinicalTrials.gov ↗
Sponsor
VNDA
Vanda Pharmaceuticals
Neuroscience
D38/100
Study Details
Enrollment100 participants
Primary Completion—
Lead SponsorVanda Pharmaceuticals
Data Retrieved2026-04-11 04:31:05.188597+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.